British Heart Foundation
Academy of Medical Sciences invests record £7.6m into early-career biomedical researchers
April 7, 2025Research and Development Academy of Medical Sciences, British Heart Foundation, Corporate, Wellcome, biomedical research, funding
The Academy of Medical Sciences has awarded £7.6m to support 62 early-career biomedical researchers across the UK, marking the largest …
12% of the UK have hearts ten years older than they are, Public Health England finds
September 4, 2017Research and Development, Sales and Marketing British Heart Foundation, Public Health England, cardiovascular disease, heart attack, heart health, stroke
New findings from Public Health England (PHE)’s Heart Age Test indicate that around 10% of men in the UK are …
Where will the next cardiovascular breakthrough come from?
August 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing British Heart Foundation, cardiovascular disease, heart, heart disease, pharma, pharmaceutical
British Heart Foundation’s Jennifer Mitchell, Research Communications Officer, explains the work they are doing to find the next breakthrough treatment …
More at risk of sudden death due to faulty heart gene than thought
February 2, 2017Medical Communications, Research and Development British Heart Foundation, faulty gene, sudden death
The British Heart Foundation has revealed that around 620,000 people are thought to be at risk of having a faulty …
UK government and partners pay £230m for disease research
October 23, 2014Research and Development, Sales and Marketing Arthritis Research UK, British Heart Foundation, Cancer Research UK, London, MRC, Osborne, UK, Wellcome Trust, dementia, research
A new partnership led by the Medical Research Council and the UK government will invest over £230 million in a …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
